Market Overview

Allergan, Novartis Enter Phase 2b Clinical Trial to Evaluate Use of Allergan's Cenicriviroc, Novartis Lead FXR Agonist to Treat NASH

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News

 

Related Articles (AGN + NVS)